Seres Therapeutics Inc
(MCRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MCRB | AZN | AMGN | GILD | VRTX |
| Company | Seres Therapeutics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 14.92 | 189.06 | 352.03 | 144.14 | 470.49 |
| High | 15.23 | 190.70 | 368.75 | 146.73 | 478.72 |
| Low | 13.04 | 186.32 | 342.38 | 143.50 | 467.10 |
| Latest | 13.63 | 187.45 | 366.20 | 146.23 | 470.52 |
| Change | -1.77 | +3.13 | +27.61 | +2.95 | +4.91 |
| % Change | -11.49% | +1.70% | +8.15% | +2.06% | +1.05% |
| Volume | 217,311 | 3,888,358 | 5,884,615 | 7,221,391 | 1,361,649 |
| 20-Day Average Volume | 51,471 | 9,146,548 | 3,013,186 | 7,918,239 | 1,500,497 |
| Previous Close | 15.40 | 184.32 | 338.59 | 143.28 | 465.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 15.36 | 107.52 | 339.05 | 131.67 | 464.22 |
| 20-Day Raw Stochastic | 17.46% | 94.85% | 94.79% | 98.18% | 70.95% |
| 20-Day Relative Strength | 40.12 | 88.34 | 66.02 | 72.83 | 55.85 |
| Weighted Alpha | -4.45 | +68.67 | +32.39 | +56.97 | +5.68 |
| Today's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 24% Sell | 88% Buy | 56% Buy | 24% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -9.97% since 01/28/26 | +101.08% since 01/28/26 | +7.01% since 01/28/26 | +4.66% since 01/28/26 | -1.55% since 01/28/26 |
| Low | 13.04 on 02/04/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 138.23 on 01/29/26 | 461.52 on 02/03/26 |
| High | 16.11 on 02/02/26 | 192.79 on 02/02/26 | 368.75 on 02/04/26 | 146.73 on 02/04/26 | 484.35 on 01/29/26 |
| 1-Month | |||||
| %Chg | -10.03% since 01/02/26 | +104.71% since 01/02/26 | +11.77% since 01/02/26 | +20.25% since 01/02/26 | +4.07% since 01/02/26 |
| Low | 13.04 on 02/04/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 16.42 on 01/14/26 | 192.79 on 02/02/26 | 368.75 on 02/04/26 | 146.73 on 02/04/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | -0.87% since 11/04/25 | +128.51% since 11/04/25 | +23.42% since 11/04/25 | +18.89% since 11/04/25 | +11.58% since 11/04/25 |
| Low | 12.48 on 11/05/25 | 81.02 on 11/05/25 | 302.13 on 11/05/25 | 116.88 on 01/05/26 | 406.67 on 11/07/25 |
| High | 29.98 on 11/20/25 | 192.79 on 02/02/26 | 368.75 on 02/04/26 | 146.73 on 02/04/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | -7.78% since 08/04/25 | +151.31% since 08/04/25 | +21.28% since 08/04/25 | +27.70% since 08/04/25 | -0.37% since 08/04/25 |
| Low | 12.48 on 11/05/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 29.98 on 11/20/25 | 192.79 on 02/02/26 | 368.75 on 02/04/26 | 146.73 on 02/04/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 139,316 | 285,863,360 | 182,324,288 | 177,764,640 | 118,134,096 |
| Shares Outstanding, K | 9,047 | 1,550,908 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 140,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 350,000 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | 8,200,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 0.22 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.94 on 11/05/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/12/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.30 | 15.76 | 17.45 | 30.83 |